Qube Research & Technologies LTD Forte Biosciences, Inc. Transaction History

Qube Research & Technologies LTD

$65.7 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 13, 2023	BUY	$0.65 - $1.04 $1 - $3	3 New	3 $0
Q2 2021 Aug 13, 2021	SELL	$31.5 - $42.5 $193,063 - $260,482	-6,129 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$25.01 - $40.24 $673,394 - $1.08 Million	-26,925 Reduced 81.46%	6,129 $210,000
Q4 2020 Feb 16, 2021	SELL	$28.66 - $46.79 $303,423 - $495,365	-10,587 Reduced 24.26%	33,054 $1.2 Million
Q3 2020 Nov 12, 2020	BUY	$14.71 - $50.69 $641,959 - $2.21 Million	43,641 New	43,641 $2.12 Million

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$977,456
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $114M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.